Methotrexate (MTX) inhibition of the growth of mouse or human leukemia cells in culture was partially prevented by either thymidine (dThd) or hypoxanthine. 5-Fluoro-2'-deoxyuridine (FdUrd) also decreased the growth-inhibitory potency of MTX in the presence of small concentrations of 5-formyltetrahydrofolate (citrovorum factor) and sufficient exogenous dThd to support the synthesis of thymidylate nucleotides by salvage mechanisms. In addition, citrovorum factorinduced reversal of MTX was several orders of magnitude more efficient in the presence of both FdUrd and dThd than in the presence of dThd alone or in the absence of both nucleosides.
transferase, EC 2.1.1.45)] or indirect (dThd and hypoxanthine; feedback inhibition by anabolites on ribonucleotide reductase and deoxycytidylate deaminase) effect. The resultant decreased rate of loss of reduced folates due to de novo thymidylate synthesis would allow a higher degree of inhibition of dihydrofolate reductase to be endured without damage to the cell. Methotrexate (MTX) is an agent of considerable clinical utility in cancer chemotherapy. Its primary biochemical mode of action has been extensively studied but is still under dispute. It is a salient yet poorly understood fact that the growth inhibitory effects of MTX on some cell lines are decreased by thymidine (dThd) alone but not by purines, whereas the inhibitory effects of MTX on other cell lines are diminished in the presence of purines but are unchanged in the presence of dThd (1, 2) . Likewise, the lethal effects of MTX are diminished by dThd in some cell lines and by purines in other cell lines (3, 4) . Yet both dThd and a source of purines are required by all cell lines examined to date to eliminate completely MTX cytotoxicity in medium supplemented with dialyzed serum (2, (5) (6) (7) (8) . Several reports have appeared of similar observations in vivo (7, (9) (10) (11) (12) . Until recently, these effects have remained a puzzle in molecular pharmacology and have had no direct implications in the clinical use of MTX. This is no longer the case: the utility of combinations of MTX and dThd for treatment of human cancer is currently being tested (13) .
We here advance the hypothesis that the decrease in the cytotoxic effects of MTX observed in the presence of dThd or purines is due to feedback effects of anabolites of these compounds, which lower the rate of de novo thymidylate synthesis [and, 
MATERIALS AND METHODS
Sera and cell culture media were purchased from GIBCO; nucleosides, MTX, citrovorum factor (CF), and other chemicals were from Sigma. CF concentrations refer to those of the dl calcium salt. Cultures were established from mycoplasma-free frozen stocks at 2.5-month intervals, and all experiments were performed on cells found negative for mycoplasma by agar techniques. The origin and methods of propagation of the L1210 and CCRF-CEM cell culture lines have been described (17, 18) . Cellular proliferation assays were performed by a modification (7) of described methods (19) . Briefly, cells were continuously exposed to drugs and metabolites during a 48- (Fig. 1) . The concentrations of dThd (5.6 MM) and hypoxanthine (32 MtM) used in these experiments were those previously found optimal to support the growth of these cells in folate-deficient medium or in the presence of high concentrations of MTX (7, 21 the medium was not significantly different than 1.0 for cells grown in unsupplemented medium or in the presence of dThd (i.e., the potency of MTX was inversely proportional to CF concentration over the concentration range tested), but the slope was 3.5 for cells grown in the presence of both FdUrd and dThd (Fig. 5) . Thus, when blockage of thymidylate synthetase was imposed on the cells, the characteristics of the reversal of MTX by CF changed from that of the competitive relationship observed in the presence of dThd alone (2, 22) to behavior more typical of end-product or "noncompetitive" reversal (2, 22) . However, the theoretical characteristic of end-product reversal (2, 22) 
DISCUSSION
The data of Borsa and Whitmore on the partial protection by dThd from the cytotoxic effects of MTX on L cells (2) have been widely quoted (23) (24) (25) (26) (27) as evidence that inhibition of dihydrofolate reductase is insufficient to explain the cytotoxic effects of MTX and have had a lasting influence on the interpretation of investigations on MTX toxicity. If a tissue or cell line undergoes less MTX-induced toxicity in the presence of dThd, it has been interpreted as evidence that the thymidylate (TMP) biosynthetic pathway is more sensitive to MTX than is the purine biosynthetic pathway; if purines decrease the toxic effect of MTX, the converse was thought to be true. Yet there has been no direct demonstration of a differential effect of MTX on the availability of the folate cofactors necessary for TMP synthesis vis a vis purine synthesis, nor has there been a report of a direct inhibitory effect of MTX on any of the enzymes that synthesize TMP, formamidoimidazole carboxamide ribonucleotide, or N-formylglycinamide ribonucleotide that is sufficiently potent to be causal in MTX toxicity (28-S1). The existence of cell lines (refs. 1, 32; Fig. 1 ) in which either dThd or purines decrease the potency of MTX argues that dThd or purines affect the development of the toxic effects of MTX by some mechanism other than that of the supply of the product of a growth ratelimiting pathway because, logically, both cannot be limiting at the same time.
For any cell being supplied with folates at the tetrahydrofolate reduction level, the only function of dihydrofolate reProc. Natl. Acad. Sci (38) . It is also known that TTP is a potent feedback inhibitor of deoxycytidylate deaminase (37, 39) and of the reduction of UDP and CDP by ribonucleotide reductase (37, 40 (Figs. 3-6) .
The mechanism of selection of thymine-requiring bacteria is relevant to our proposed hypothesis: such mutants are exposed to toxic concentrations of antifolates in the presence of thymine or dThd. In the vast majority of mutant bacteria selected by this procedure, thymidylate synthetase has been deleted or substantially reduced (42) . Hence, the mutant bacteria are unaffected by inhibition of dihydrofolate reductase by virtue of the fact that the tetrahydrofolate cofactor pools are not depleted by de novo TMP synthesis. A eukaryotic analog is known: the S-180/AT cell, which was selected for MTX resistance in the presence of dThd and has 1/30th the thymidylate synthetase activity of the parent cell line (1, 43) .
A consideration of the role of thymidylate synthetase in the development of MTX cytotoxicity and of the previously discussed indirect effect of TTP on the loss of cellular folates would explain several perplexing phenomena: (i) Partial protection by dThd against toxic effects of MTX observed in cell culture and in vivo (refs. 1, 2, 9-13, Fig. 1 ).
(ii) Partial protection by purines against toxic effects of MTX ( refs. 1, 4; Fig. 1 ). The decreased toxicity of MTX observed in some cells in the presence of deoxyadenosine or hypoxanthine could be due to feedback effects of purine anabolites on the availability of dUMP. Thus, ATP and dATP are strong allosteric effectors of ribonucleotide reductase (40) , and dAMP is a competitive inhibitor of homogeneous deoxycytidylate deaminase from donkey spleen (44) .
(iii) Deoxycytidine reversal of dThd-induced alterations in toxic effects of MTX (2) . In the presence of deoxycytidine, the dUMP pool would be expanded in spite of the presence of dThd, due to a reversal by dCTP of the TTP inhibition of deoxycytidylate deaminase. Such an effect has been documented with purified mammalian deoxycytidylate deaminase (39) . Our hypothesis predicts that expansion of the dUMP pool, caused by any exogenous cytidine or uridine nucleoside, should eliminate the dThd-induced protection against MTX. Our experiments to date have indicated that this is the case (unpublished observations). At appropriate concentrations, deoxycytidine, deoxyuridine, cytidine, and uridine offset the effect of dThd on MTX toxicity in L1210 cells (data not shown); deoxycytidine was by far the most potent nucleoside of this series in this regard. The mechanism of these effects can be examined by using a newly developed microassay for dUMP (45) .
(iv) Competitive relationship between MTX and CF observed under most conditions (refs. 1, 2, 8, and 10; Fig. 4 ). In the presence of thymidylate synthetase activity, this could be due to accumulation of folate pools in the form of dihydrofolate or dihydrofolate polyglutamates (46) (47) (48) , thereby causing a direct competition between substrate and inhibitor of dihydrofolate reductase. At cellular pH, MTX is a competitive inhibitor of dihydrofolate reductase, albeit a potent one (49) . The work of Jackson et al. (48, 50) and Meyers et al. (51) suggests that the dissociation constant of the MTX-enzyme complex would be compatible with such a competition.
(v) Noncompetitive reversal of effects of MTX by CF in the presence of dThd in L cells (2) . If TTP accumulates in the presence of dThd and decreases or eliminates dUMP pools, and thereby de novo TMP synthesis, an exogenous concentration of CF that supplies formylated cofactor levels sufficient for purine synthesis would reverse the toxicity of any concentration of MTX. It is clear that a direct pharmacological inhibition of thymidylate synthetase is necessary to bring about a blockade of sufficient intensity to demonstrate a noncompetitive pattern of CF reversal in L1210 cells (Fig. 3-5 ), suggesting that there is a basic difference in the regulation of dUMP synthesis between L1210 and L cells. The extensive protection by dThd against the lethal effects of MTX seen in mice (10) and humans (13) is remarkable and not easily understood. One explanation of this phenomenon is that the dUMP pool in dividing stem cells of the gut and bone marrow is sensitive to depletion by the type of feedback effects we now postulate to be involved in Borsa and Whitmore's L cells (2) . If this were the case, high-dose MTX-dThd rescue (13) or high-dose MTX-CF rescue combined with continuous low-dose dThd infusions should be effective therapy for any tumor, the dUMP pool of which was relatively unresponsive to exogenous dThd.
(vi) Competitive reversal of MTX by CF in L cells in the presence of dThd and deoxycytidine (2) . With the addition of deoxycytidine together with dThd, dUMP pools and de novo TMP synthesis would be reinstated and dihydrofolate reductase would again be necessary for cell growth.
The role we postulate here that cellular thymidylate synthetase activity plays in the development of the cytotoxicity of MTX is best demonstrated by the virtual elimination of cytotoxicity and growth inhibition by MTX in the presence of FdUrd (and, of course, sufficient CF and dThd) (Figs. 3-6) . § A third possible pathway for the synthesis of dUMP via phosphorylation of 2'-deoxyuridine has been recently postulated (37) . It would also be subject to feedback inhibition by TTP (41 Although antagonism between fluorinated pyrimidines and MTX has been demonstrated on short-term effects such as isotope incorporation (16, 52) , only limited antagonism has been observed by utilizing tumor growth (14, 15) . It is now clear (Fig.  6 ) that the potential for a decreased tumor cell kill with combinations of MTX and FdUrd is far greater than that previously documented, if reduced folate cofactors and dThd are available to the tumor. This study also suggests that thymidylate synthetase activity will be a major determinant of the amount of CF required to rescue any given tissue during high-dose MTX chemotherapy. Thus, a tumor with high thymidylate synthetase activity might be a poor candidate for chemotherapy with fluorinated pyrimidines, but an excellent choice for high-dose MTX-CF rescue. In addition, the explanation we offer in this report for the decreased cytotoxic effects of MTX observed in the presence of dThd alone or purine alone (refs. 1-4; Fig. 1 
